217 related articles for article (PubMed ID: 23365264)
1. External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer.
Ariga T; Toita T; Kasuya G; Nagai Y; Inamine M; Kudaka W; Kakinohana Y; Aoki Y; Murayama S
J Radiat Res; 2013 Jul; 54(4):690-6. PubMed ID: 23365264
[TBL] [Abstract][Full Text] [Related]
2. Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
Wujanto C; Choo BA; Tan D; Ilancheran A; Ng J; Low JJH; Shen L; Tang J; Koh V
BMC Cancer; 2019 Apr; 19(1):385. PubMed ID: 31023261
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
[TBL] [Abstract][Full Text] [Related]
4. The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer.
Lee YC; Rash DL; Stern RL; Mayadev JS
Brachytherapy; 2013; 12(6):555-9. PubMed ID: 23880417
[TBL] [Abstract][Full Text] [Related]
5. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
6. Who can benefit from a lymph node boost in definitive chemoradiotherapy for node-positive cervical cancer: an evaluation of nodal failure in patients without nodal boost.
Kim H; Park W; Cho WK
J Radiat Res; 2020 May; 61(3):479-486. PubMed ID: 32211854
[TBL] [Abstract][Full Text] [Related]
7. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
Ito K; Shimizuguchi T; Karasawa K
Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy.
Choi KH; Kim JY; Lee DS; Lee YH; Lee SW; Sung S; Park HH; Yoon SC; Hur SY; Park JS; Kim YS
Medicine (Baltimore); 2018 Apr; 97(16):e0517. PubMed ID: 29668638
[TBL] [Abstract][Full Text] [Related]
10. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
[TBL] [Abstract][Full Text] [Related]
11. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
[TBL] [Abstract][Full Text] [Related]
12. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer.
Cihoric N; Tsikkinis A; Tapia C; Aebersold DM; Zlobec I; Lössl K
Radiat Oncol; 2015 Nov; 10():240. PubMed ID: 26597282
[TBL] [Abstract][Full Text] [Related]
13. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
[TBL] [Abstract][Full Text] [Related]
14. Postoperative external beam irradiation with and without brachytherapy in pelvic node-positive IB1-IIA2 cervical cancer patients: a retrospective clinical study.
Li L; Kou X; Feng X; Zhang M; Chao H; Wang L
Radiat Oncol; 2015 Sep; 10():189. PubMed ID: 26377326
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG-PET/CT guided external beam radiotherapy volumes in inoperable uterine cervical cancer.
Adam JA; Arkies H; Hinnen K; Stalpers LJ; van Waesberghe JH; Stoker J; van Os R; Laan JJ; Mom CH; van Eck-Smit BL
Q J Nucl Med Mol Imaging; 2018 Dec; 62(4):420-428. PubMed ID: 29869485
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
[TBL] [Abstract][Full Text] [Related]
17. Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
Ramlov A; Kroon PS; Jürgenliemk-Schulz IM; De Leeuw AA; Gormsen LC; Fokdal LU; Tanderup K; Lindegaard JC
Acta Oncol; 2015; 54(9):1567-73. PubMed ID: 26271799
[TBL] [Abstract][Full Text] [Related]
18. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
[TBL] [Abstract][Full Text] [Related]
19. Impact of nodal boost irradiation and MR-based brachytherapy on oncologic outcomes in node-positive cervical cancer.
Tiwari R; Narayanan GS; Reddy VP; Vishwanathan B; Narayanan S; Venugopal R
Gynecol Oncol; 2021 Oct; 163(1):110-116. PubMed ID: 34304907
[TBL] [Abstract][Full Text] [Related]
20. Pulsed low dose rate brachytherapy for uterine cervix carcinoma.
Rogers CL; Freel JH; Speiser BL
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):95-100. PubMed ID: 9989519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
